SYRA vs. ONFO, VCIG, FRGT, XYLO, ATXG, AUUD, MRIN, TGL, DKDCA, and STAF
Should you be buying Syra Health stock or one of its competitors? The main competitors of Syra Health include Onfolio (ONFO), VCI Global (VCIG), Freight Technologies (FRGT), Xylo Technologies (XYLO), Addentax Group (ATXG), Auddia (AUUD), Marin Software (MRIN), Treasure Global (TGL), Data Knights Acquisition (DKDCA), and Staffing 360 Solutions (STAF). These companies are all part of the "business services" industry.
Syra Health vs. Its Competitors
Onfolio (NASDAQ:ONFO) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.
Onfolio has a beta of 2.7, indicating that its stock price is 170% more volatile than the S&P 500. Comparatively, Syra Health has a beta of 3.85, indicating that its stock price is 285% more volatile than the S&P 500.
In the previous week, Onfolio had 5 more articles in the media than Syra Health. MarketBeat recorded 6 mentions for Onfolio and 1 mentions for Syra Health. Onfolio's average media sentiment score of 1.16 beat Syra Health's score of 0.05 indicating that Onfolio is being referred to more favorably in the media.
Onfolio has higher earnings, but lower revenue than Syra Health. Onfolio is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.
0.8% of Onfolio shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 32.4% of Onfolio shares are held by company insiders. Comparatively, 10.2% of Syra Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Onfolio has a net margin of -21.25% compared to Syra Health's net margin of -54.90%. Onfolio's return on equity of -42.11% beat Syra Health's return on equity.
Summary
Onfolio beats Syra Health on 8 of the 13 factors compared between the two stocks.
Get Syra Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYRA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Syra Health Competitors List
Related Companies and Tools
This page (NASDAQ:SYRA) was last updated on 7/5/2025 by MarketBeat.com Staff